IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.6257
-0.0143 (-2.23%)
At close: Dec 16, 2025, 4:00 PM EST
0.6290
+0.0033 (0.53%)
After-hours: Dec 16, 2025, 6:56 PM EST

Company Description

IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.

The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.

It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors.

The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

IceCure Medical Ltd
IceCure Medical logo
CountryIsrael
Founded2006
IndustryMedical Devices
SectorHealthcare
Employees66
CEOEyal Shamir

Contact Details

Address:
7 Ha’Eshel Street, PO Box 3163
Caesarea, 3079504
Israel
Phone972 4 623 0333
Websiteicecure-medical.com

Stock Details

Ticker SymbolICCM
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$0.00
CIK Code1584371
CUSIP NumberM53071136
ISIN NumberIL0011224156
SIC Code3841

Key Executives

NamePosition
Eyal ShamirChief Executive Officer and Director
Ronen Tsimerman CPAChief Financial Officer
Shay LevavChief Operating Officer
Tlalit Bussi Tel-TzureVice President of Business Development and Global Marketing
Shad GoodVice President of Sales for North America
Merav Nir DotanVice President of Human Resources
Galit MalikVice President of Operations and Service

Latest SEC Filings

DateTypeTitle
Dec 10, 20256-KReport of foreign issuer
Dec 5, 20256-KReport of foreign issuer
Dec 3, 20256-KReport of foreign issuer
Nov 19, 20256-KReport of foreign issuer
Nov 18, 20256-KReport of foreign issuer
Nov 14, 20256-KReport of foreign issuer
Nov 10, 20256-KReport of foreign issuer
Nov 3, 20256-KReport of foreign issuer
Oct 17, 20256-KReport of foreign issuer
Oct 3, 20256-KReport of foreign issuer